BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 29753159)

  • 1. Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.
    McDonald MK; Culos KA; Gatwood KS; Prow C; Chen H; Savani BN; Byrne M; Kassim AA; Engelhardt BG; Jagasia M; Satyanarayana G
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):2081-2087. PubMed ID: 29753159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(8):243-8. PubMed ID: 21368740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.
    Lukenbill J; Rybicki L; Sekeres MA; Zaman MO; Copelan A; Haddad H; Fraser T; DiGiorgio MJ; Hanna R; Duong H; Hill B; Kalaycio M; Sobecks R; Bolwell B; Copelan E
    Biol Blood Marrow Transplant; 2013 May; 19(5):720-4. PubMed ID: 23380342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary artery catheter epidemiology of risk in pre-heart-transplant recipients.
    Yetmar ZA; Lahr B; O'Horo J; Behfar A; Sampathkumar P; Beam E
    Infect Control Hosp Epidemiol; 2019 Jun; 40(6):632-638. PubMed ID: 31038098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.
    Dandoy CE; Haslam D; Lane A; Jodele S; Demmel K; El-Bietar J; Flesch L; Myers KC; Pate A; Rotz S; Daniels P; Wallace G; Nelson A; Waters H; Connelly B; Davies SM
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1671-1677. PubMed ID: 27311966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
    Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial bloodstream infections in pediatric allogeneic hematopoietic stem cell recipients before and after implementation of a central line-associated bloodstream infection protocol: A single-center experience.
    Chang AK; Foca MD; Jin Z; Vasudev R; Laird M; Schwartz S; Qureshi M; Kolb M; Levinson A; Bhatia M; Kung A; Garvin J; George D; Della-Latta P; Whittier S; Saiman L; Satwani P
    Am J Infect Control; 2016 Dec; 44(12):1650-1655. PubMed ID: 27378008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repair of damaged central venous catheters is safe and doubles catheter survival: a home parenteral nutrition patient cohort study.
    Wouters Y; Vissers RK; Groenewoud H; Kievit W; Wanten GJA
    Clin Nutr; 2019 Aug; 38(4):1692-1699. PubMed ID: 30146167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive strategies for central line-associated bloodstream infections in pediatric hematopoietic stem cell transplant recipients.
    Barrell C; Covington L; Bhatia M; Robison J; Patel S; Jacobson JS; Buet A; Graham PL; Saiman L
    Am J Infect Control; 2012 Jun; 40(5):434-9. PubMed ID: 21907455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study.
    Pitiriga V; Bakalis J; Kampos E; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Jul; 11(1):96. PubMed ID: 35841083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of intensive care unit-acquired central line-associated bloodstream infection on in-hospital mortality: A single-center risk-adjusted analysis.
    Wong SW; Gantner D; McGloughlin S; Leong T; Worth LJ; Klintworth G; Scheinkestel C; Pilcher D; Cheng AC; Udy AA
    Am J Infect Control; 2016 May; 44(5):587-92. PubMed ID: 26874406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for central line-associated bloodstream infections in the era of best practice.
    Lissauer ME; Leekha S; Preas MA; Thom KA; Johnson SB
    J Trauma Acute Care Surg; 2012 May; 72(5):1174-80. PubMed ID: 22673242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central line-associated bloodstream infections among critically-ill patients in the era of bundle care.
    Lin KY; Cheng A; Chang YC; Hung MC; Wang JT; Sheng WH; Hseuh PR; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2017 Jun; 50(3):339-348. PubMed ID: 26316008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Viral Infections after Antithymocyte Globulin-Based Conditioning in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
    Figgins B; Hammerstrom A; Ariza-Heredia E; Oran B; Milton DR; Yeh J
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1837-1843. PubMed ID: 31128324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central line-associated bloodstream infection in neonatal intensive care units.
    Blanchard AC; Fortin E; Rocher I; Moore DL; Frenette C; Tremblay C; Quach C
    Infect Control Hosp Epidemiol; 2013 Nov; 34(11):1167-73. PubMed ID: 24113600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention Practices.
    Theodoro D; Olsen MA; Warren DK; McMullen KM; Asaro P; Henderson A; Tozier M; Fraser V
    Acad Emerg Med; 2015 Sep; 22(9):1048-55. PubMed ID: 26336036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
    Ali N; Adil SN; Shaikh MU
    Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.
    Kelly M; Conway M; Wirth K; Potter-Bynoe G; Billett AL; Sandora TJ
    Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1079-85. PubMed ID: 22011534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of central line-associated bloodstream infections in Quebec intensive care units: a 6-year review.
    Fontela PS; Platt RW; Rocher I; Frenette C; Moore D; Fortin E; Buckeridge D; Pai M; Quach C
    Am J Infect Control; 2012 Apr; 40(3):221-6. PubMed ID: 21824682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.